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Abstract. 
 
The survival of motor neurons (SMN) pro-
tein, the product of the neurodegenerative disease spi-
nal muscular atrophy (SMA) gene, is localized both in 
the cytoplasm and in discrete nuclear bodies called 
gems. In both compartments SMN is part of a large 
complex that contains several proteins including 
Gemin2 (formerly SIP1) and the DEAD box protein 
Gemin3. In the cytoplasm, the SMN complex is associ-
ated with snRNP Sm core proteins and plays a critical 
role in spliceosomal snRNP assembly. In the nucleus, 
SMN is required for pre-mRNA splicing by serving in 
the regeneration of spliceosomes. These functions are 
likely impaired in cells of SMA patients because they 
have reduced levels of functional SMN. Here, we report 
the identiﬁcation by nanoelectrospray mass spectrome-
try of a novel component of the SMN complex that we 
name Gemin4. Gemin4 is associated in vivo with the 
SMN complex through a direct interaction with 
Gemin3. The tight interaction of Gemin4 with Gemin3 
suggests that it could serve as a cofactor of this DEAD 
box protein. Gemin4 also interacts directly with several 
of the Sm core proteins. Monoclonal antibodies against 
Gemin4 efﬁciently immunoprecipitate the spliceosomal 
U snRNAs U1 and U5 from 
 
Xenopus
 
 oocytes cyto-
plasm. Immunolocalization experiments show that 
Gemin4 is colocalized with SMN in the cytoplasm and 
in gems. Interestingly, Gemin4 is also detected in the 
nucleoli, suggesting that the SMN complex may also 
function in preribosomal RNA processing or ribosome 
assembly.
Key words: gems • nucleoli • SMN • spinal muscular 
atrophy • snRNP biogenesis
 
Introduction
 
Spinal muscular atrophy (SMA)
 
1
 
 is a common autoso-
mal recessive disease that is the leading hereditary cause
of infant mortality. SMA is characterized by degenera-
tion of motor neurons of the anterior horn of the spinal
cord resulting in muscular weakness and atrophy (Pearn,
1980; for review see Melki, 1999). SMA results from de-
letions or mutations in the survival of motor neurons
 
gene (
 
SMN
 
), which is duplicated as an inverted repeat
on human chromosome 5 at 5q13 (Brzustowicz et al.,
1990; Melki et al., 1990, 1994). The telomeric copy of the
 
SMN
 
 gene (
 
SMN1
 
) is deleted or mutated in 
 
.
 
98% of
SMA patients (Lefebvre et al., 1995; for review see
Burghes, 1997). The SMN protein is expressed in all tis-
sues of mammalian organisms with particularly high lev-
els expressed in motor neurons (Coovert et al., 1997;
Lefebvre et al., 1997). In contrast, individuals affected
by the most severe form of SMA, Werdnig-Hoffman
syndrome or SMA type I, have barely detectable levels
of SMN in motor neurons (Coovert et al., 1997; Lefebvre
et al., 1997).
The SMN protein is part of a multiprotein complex and
two other proteins of the complex, Gemin2 (formerly
SIP1) and Gemin3 (for component of gems 2 and 3, re-
spectively) thus far have been characterized (Liu et al.,
1997; Charroux et al., 1999). SMN, Gemin2, and Gemin3
localize in the cytoplasm and the nucleus of somatic cells.
In the nucleus, they are concentrated in bodies called
gems, which are similar in size and number to coiled bod-
ies (CBs) and are often associated with them (Liu and
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Dreyfuss, 1996; Liu et al., 1997; Charroux et al., 1999). In
addition to SMN, Gemin2 and Gemin3, the large cytoplas-
mic complex of which they are part also contains Sm pro-
teins that are components of spliceosomal small nuclear
ribonucleoprotein (snRNPs; Liu et al., 1997; Charroux et
al., 1999). SMN interacts directly with the Sm proteins
and with Gemin2 and Gemin3 (Liu et al., 1997; Charroux
et al., 1999; Pellizzoni et al., 1999). Antibody microin-
jection experiments in 
 
Xenopus 
 
oocytes revealed that
Gemin2 has a critical role in the assembly of snRNPs
(Fischer et al., 1997), a process which takes place in the cy-
toplasm where the Sm proteins combine with snRNAs
that were exported from the nucleus (Mattaj and De Ro-
bertis, 1985; Mattaj, 1988; Luhrmann et al., 1990). Once
properly assembled and modified, the snRNPs recruit the
necessary nuclear import receptors and translocate into
the nucleus where they function in pre-mRNA splicing
(Mattaj, 1986, 1988; Luhrmann et al., 1990; Neuman de
Vegvar and Dahlberg, 1990; Zieve and Sauterer, 1990).
Transfections of a dominant negative form of SMN
(SMN
 
D
 
N27) revealed that SMN also plays a critical role
in the cytoplasmic assembly of snRNPs (Pellizzoni et al.,
1998). In the nucleus, overexpression of the SMN
 
D
 
N27
protein causes a striking rearrangement of the snRNPs,
which accumulate with the mutant SMN
 
D
 
N27 in enlarged
gem/coiled body structures (Pellizzoni et al., 1998). SMN
has been further shown to be required for pre-mRNA
splicing, likely for the regeneration or recycling of sn-
RNPs (Pellizzoni et al., 1998). Of the known components
of the SMN complex, the recently described DEAD box
protein Gemin3 is the most likely candidate to have the
capacity to perform such functions (Charroux et al.,
1999). Interestingly, SMN mutants found in SMA patients
lack the snRNP regeneration activity likely because of
their defective interaction with the Sm proteins as well as
with Gemin3 (Pellizzoni et al., 1998, 1999; Charroux et al.,
1999).
Here, we report the amino acid sequencing by nano-
electrospray mass spectrometry (Wilm et al., 1996) and
molecular cloning of a novel component of the SMN
complex designated Gemin4 (available from GenBank/
EMBL/DDBJ under accession number AF173856). Sev-
eral lines of evidence suggest that Gemin4 participates
in the functions of the SMN complex. Together with
SMN, Gemin2 and Gemin3, Gemin4 can be isolated in a
complex with the spliceosomal snRNP proteins. The
presence of Gemin4 in the SMN complex in vivo is a re-
sult of its direct interaction with Gemin3 but not with
SMN. Gemin4 also interacts directly with several of the
spliceosomal snRNP core Sm proteins, including SmB,
SmD1-3, and SmE, and is associated with U snRNAs in
the cytoplasm of 
 
Xenopus
 
 oocytes. Gemin4 is a novel
protein and shows no significant homology to any other
protein found in the databases. Its tight association with
Gemin3 suggests that it may act as a cofactor of the pu-
tative ATPase and/or helicase activity of Gemin3. We
have produced mAbs to Gemin4, and show by immuno-
fluorescence microscopy that it colocalizes with SMN in
gems. Interestingly, unlike other gems proteins described
so far, Gemin4 is also detected in the nucleolus, suggest-
ing that it may have additional functions in ribosome
biogenesis.
 
Materials and Methods
 
Production of Proteins In Vitro
 
Proteins were labeled with [
 
35
 
S]methionine by an in vitro coupled tran-
scription-translation reaction (Promega Biotech). His-tagged Gemin4 (amino
acids 611–1,058) and His-tagged SmB fusion proteins were expressed from
pET28a in 
 
Escherichia coli
 
 strain BL21(DE3) and purified on nickel
columns according to the manufacturer’s recommendations. GST, GST-
Gemin3, and GST-Gemin4 fusion proteins were expressed from pGEX-
5X-3 (Pharmacia) in 
 
E. coli
 
 strain BL21 and purified using glutathione-
Sepharose (Pharmacia) according the manufacturer’s protocol.
 
Production of mAbs to Gemin4
 
Anti-Gemin4 antibody 22C10 was prepared by immunizing Balb/C mice
with a His-tagged COOH-terminal fragment of Gemin4. Hybridoma pro-
duction, screening, and ascites fluid production were performed as previ-
ously described (Choi and Dreyfuss, 1984).
 
Immunoprecipitation and Immunoblotting
 
Immunoprecipitations of in vitro translated proteins were carried out in
the presence of 1% Empigen BB buffer as previously described (Choi and
Dreyfuss, 1984). Coimmunoprecipitations were carried out using total
HeLa lysate in the presence of 0.5% Triton X-100 as previously described
(Pinol-Roma et al., 1988). For immunoblotting, proteins were resolved on
12.5% SDS–polyacrylamide gels and transferred to nitrocellulose mem-
branes (Schleider and Schuell, Inc.) using a BioTrans Transblot apparatus
(model B; Gelman Science) according to the manufacturer’s instructions.
The membranes were incubated in blocking solution (PBS 5% nonfat
milk) for at least 1 h at room temperature, rinsed with cold PBS, and incu-
bated in blocking solution with primary antibody for at least 1 h at room
temperature. Membranes were washed three times in PBS containing
0.05% NP-40, followed by incubation with peroxidase-conjugated second-
ary antibodies (Jackson ImmunoResearch Laboratories, Inc.), which were
visualized by an ECL Western blotting kit (Amersham) after three addi-
tional washes with PBS containing 0.05% NP-40.
 
Cell Culture
 
HeLa cells were cultured in DME supplemented with 10% FBS (both
from GIBCO BRL).
 
Immunofluorescence Microscopy
 
Immunofluorescence staining was carried out essentially as previously de-
scribed (Choi and Dreyfuss, 1984). Double-labeled immunofluorescence
experiments were performed by separate, sequential incubations of each
primary antibody diluted in PBS containing 3% BSA, followed by the spe-
cific secondary antibody coupled to either FITC or Texas red. All incuba-
tions were carried out at room temperature for 1 h. Laser confocal fluo-
rescence microscopy was performed with a Leica TCS 4D confocal
microscope. Images from each channel were recorded separately and,
where indicated, the files were merged. Antibodies used in these experi-
ments were as follows: mouse IgG1 monoclonal anti-Gemin4 (22C10; this
work); mouse IgG1 monoclonal anti-SMN (2B1; Liu and Dreyfuss, 1996);
rabbit polyserum anti-p80 coilin (R288; Andrade et al., 1991); mouse IgG3
monoclonal anti-Sm (Y12; Lerner et al., 1981); human autoimmune anti-
body against fibrillarin 1881 (Reimer et al., 1987); and rabbit affinity-puri-
fied anti-SMN exon 7 epitope antibody (Liu et al., 1997).
 
In Vitro Protein-binding Assay
 
Purified GST or GST fusion proteins (2 
 
m
 
g) bound to 25 
 
m
 
l of glutathione-
Sepharose beads were incubated with 10
 
6
 
 cpm of in vitro translated pro-
tein in 1 ml of binding buffer (50 mM Tris-HCl, pH 7.5, 200 mM NaCl,
2 mM EDTA, 0.1% NP-40, 2 
 
m
 
g/ml leupeptin and pepstatin A, and 0.5%
aprotinin). After incubation for 1 h at 4
 
8
 
C, the resin was washed five times
with 1 ml of binding buffer. The bound fraction was eluted by boiling in
SDS-PAGE sample buffer and run on SDS-PAGE. The gels were fixed
for 30 min and the signal was enhanced by treatment with Amplify solu-
tion (Amersham). For direct in vitro binding, we used 5 
 
m
 
g of purified
His-tagged SmB and a binding buffer (50 mM Tris-HCl, pH 7.5, 100 mM
NaCl, 2 mM EDTA, 0.05% NP-40, 2 
 
m
 
g/ml leupeptin and pepstatin A, 
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and 0.5% aprotinin). The binding experiment was performed as described
above, except that bound His-tagged SmB proteins were immunodetected
by Western blot using a rabbit polyclonal anti-His tag antibody (Santa
Cruz Biotechnology).
 
Gel Filtration
 
Total HeLa cell extract prepared in RSB-100 was loaded on a Superose 6
HR 10/30 column (Pharmacia). The column was washed with RSB-100 at
a flow rate 0.5 ml/min. Fractions (1 min) were collected, and 1:20 of each
fraction was resolved on SDS-PAGE followed by Western blotting.
 
Oocyte Injections and Immunoprecipitation of
RNA–Protein Complexes
 
Injections were carried out as previously described (Fischer et al., 1993). In
brief, oocytes were incubated for 3 h in modified Barth’s solution contain-
ing 0.2% collagenase type II (Sigma Chemical Co.). Defolliculated stage
V and VI oocytes were collected and usually used the day after for micro-
injection. In a typical injection experiment, 30 nl of 
 
32
 
P-labeled RNA (10
 
6
 
cpm/
 
m
 
l; total concentration of 0.7 
 
m
 
M) was injected into the cytoplasm.
For immunoprecipitation of RNA–protein complexes (Fisher et al., 1993),
the injected oocytes were homogenized in 300 
 
m
 
l of ice-cold PBS, pH 7.4.
The insoluble fraction was pelleted by centrifugation, and the clear super-
natant was transferred into a new 1.5-ml Eppendorf tube containing anti-
bodies bound to protein G–Sepharose (Pharmacia). This mixture was in-
cubated with constant shaking for 1 h at 4
 
8
 
C and subsequently washed five
times with 1 ml of ice-cold PBS. Bound RNAs were isolated by phenol ex-
traction for 1 h, precipitated with ethanol, and analyzed by denaturing gel
electrophoresis.
 
Plasmid DNA and In Vitro Transcription
 
In vitro transcription of 
 
32
 
P-labeled RNAs was carried out as described in
Fisher et al. (1993) from plasmids encoding for U1, U2, U4, and U5 sn-
RNAs. The plasmid encoding the chicken 
 
d
 
-crystallin pre-mRNA was
previously described (Pellizzoni et al., 1998). The plasmid encoding the
chicken 
 
d
 
-crystallin mRNA was constructed by elution of the chicken
 
d
 
-crystallin mRNA from polyacrylamide gel followed by reverse tran-
scriptase–PCR and subcloning into pSP65 (pSP1415m; Promega Corp).
The plasmids used for in vitro transcription and translation of SMN,
Gemin2, Gemin3, and the Sm proteins have been previously described
(Charroux et al., 1999; Pellizzoni et al., 1999).
 
Results
 
Gemin4, a Novel Component of the SMN Complex
 
Immunoprecipitations from [
 
35
 
S]methionine-labeled HeLa
cell lysates with anti-SMN mAbs revealed the presence of
several protein components in the SMN complex (Liu et al.,
1997). Proteins that coimmunopurify with anti-SMN anti-
bodies (Fig. 1) include Sm proteins, Gemin2 (Liu et al.,
1997), and the recently described DEAD box protein
Gemin3 (Charroux et al., 1999). In addition to these pro-
teins, there are bands of 175, 97, 95, 60, and 50 kD that
coimmunopurified with SMN (Fig. 1). In this paper, we de-
scribe the molecular cloning and characterization of the
97-kD polypeptide. The p97 band was digested in gel by
trypsin, and the resulting peptides were sequenced by
nanoelectrospray mass spectrometry as described previ-
ously (Shevchenko et al., 1996; Wilm et al., 1996). Search-
ing the databases with several peptides from this band
(using the peptide sequence tag algorithm) we identified
a human expressed sequence tag sequence (clone no.
R55454) (Shevchenko et al., 1996). Several additional
cDNA clones were obtained by hybridization screening of
a human leukemia 5
 
9
 
-STRETCH PLUS cDNA library us-
ing the expressed sequence tag clone as a probe. We iso-
lated 20 independent partial cDNA clones with insert sizes
ranging from 0.8 to 3.1 kb, all of which contained overlap-
ping regions of the same open reading frame (ORF). A
cDNA clone containing the longest ORF was constructed,
and conceptual translation of its nucleotide sequence re-
vealed a potential initiator methionine preceded by an in-
frame stop codon. This cDNA encodes a putative protein
of 1,058 amino acids with a calculated molecular mass of
119.9 kD and an estimated pI of 5.68. Database searches
with the full-length clone did not reveal significant homol-
ogy to any other protein or any recognizable motifs. Thus,
this is a full-length cDNA clone that encodes a novel com-
ponent of the SMN complex (see below), which we termed
Gemin4 for component of gems number 4.
 
Production of Monoclonal Antibodies to Gemin4
 
To investigate the interaction of Gemin4 with SMN and to
characterize Gemin4 further, we generated mAbs by im-
munizing mice with a bacterially produced, purified re-
combinant His-tagged Gemin4 fragment (from amino ac-
ids 611 to 1,058). One hybridoma, 22C10, was selected for
additional studies. Several lines of evidence demonstrate
that this hybridoma indeed produced mAb that recognizes
Gemin4 specifically. First, 22C10 immunoprecipitated
Gemin4 produced by in vitro transcription and translation
from the Gemin4 cDNA but not similarly produced
hnRNP A1 or SMN proteins (Fig. 2 A). Second, on an im-
munoblot of total HeLa lysate, 22C10 recognized a single
protein of
 
 
 
z
 
97 kD (Fig. 2 B). Finally, 22C10 specifically
immunoprecipitated a single protein of 
 
z
 
97 kD from
[
 
35
 
S]methionine-labeled HeLa and mouse 3T3 cell lysates
(Fig. 2 C), suggesting that Gemin4, like SMN, is conserved
in vertebrates.
 
Gemin4 Is Localized both in Gems and in Nucleoli
 
Indirect immunofluorescence laser confocal microscopy
using mAb 22C10 was performed on HeLa cells to deter-
mine the subcellular localization of Gemin4. Fig. 3, A and
Figure 1. Immunoprecipitation of
the SMN complex with mAb
against SMN. Immunoprecipita-
tions using anti-SMN mAb 2B1 and
[35S]methionine-labeled HeLa cell
cytoplasmic extract. The immuno-
precipitated proteins were analyzed
by SDS-PAGE and autoradiogra-
phy. Antibody 2B1 (lane 2B1) im-
munoprecipitates SMN, Gemin2,
Gemin3, Sm proteins B, B9, D1-3,
E, F, and G, and a group of proteins
indicated as p175, p97, p95, p60,
and p50. The SP2/0 lane shows the
background of immunoprecipita-
tion (lane SP2/0). The position of
the molecular mass markers is indi-
cated on the left in kilodaltons. 
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C, shows that anti-Gemin4 antibodies display intense
staining of prominent discrete bodies in the nucleus, and
these are also readily discernible by differential interfer-
ence contrast (Fig. 3 D). In addition, the 22C10 antibody
stained nucleoli (see below). To determine if the discrete
nuclear structures stained by 22C10 are gems or CBs, we
performed double label immunofluorescence experiments
using antibodies against Gemin4 and either p80-coilin, as a
marker of CBs (Andrade et al., 1991), or SMN, as a
marker of gems (Liu and Dreyfuss, 1996). In many cell
lines, the antibody staining of gems and CBs entirely over-
lap, however, in the HeLa PV strain used here these two
bodies are frequently found separate from each other (Liu
and Dreyfuss, 1996; Matera and Frey, 1998). In a recent
report, Carvalho et al. (1999) have also observed that
gems are often detected separately from CBs. The nuclear
structures that contain Gemin4 are clearly distinct from
CBs but are completely colocalized with SMN in gems
(Fig. 3, B, C, and E). The colocalization of Gemin4 with
SMN strongly supports the conclusion that these two pro-
teins exist as a complex in the cell. Thus, Gemin4 is the
fourth constituent of gems described so far. Like staining
with antibodies to SMN, Gemin2 and Gemin3, 22C10
shows a diffuse cytoplasmic staining for Gemin4 (Fig. 3 A).
To further study the nucleolar staining of Gemin4, we
performed double label immunofluorescence experiments
using the Gemin4 antibody 22C10 and the fibrillarin anti-
body 1881 as a marker of the nucleolus (Raska et al., 1990).
The staining, shown in Fig. 3 F, indicates that Gemin4 and
fibrillarin do not colocalize, but both show distinct nucle-
olar patterns. This demonstrates that Gemin4 is present in
the nucleolus but excluded from the dense fibrillar com-
partment of the nucleolus (Ochs and Smetana, 1991). Thus,
Gemin4 represents the first component of the SMN com-
plex that localizes both in gems and nucleoli (see Discus-
sion).
 
Gemin4 Is in a Complex with SMN, Gemin2
and Gemin3
 
To characterize the Gemin4-containing complex, we tested
for its presence in the SMN complex in vivo by coimmuno-
precipitation and Western blotting experiments. The anti-
Gemin4 mAb 22C10 was used for immunoprecipitation
from HeLa cell total extracts, and these were resolved by
SDS-PAGE, immunoblotted, and probed with the anti-
SMN antibody 2B1 (Liu and Dreyfuss, 1996). As shown in
Fig. 4 A (lane 22C10 IP), 2B1 readily detects SMN in the
22C10 immunoprecipitates, indicating that SMN is coim-
munoprecipitated with Gemin4. Because SMN forms a
stable complex with Gemin2 in vivo and in vitro (Liu et al.,
1997), we also investigated whether Gemin2 could be
coimmunoprecipitated with Gemin4. As shown in Fig. 4
A, the anti-Gemin2 mAb 2S7 clearly detects Gemin2 in
the anti-Gemin4 immunoprecipitates (lane 22C10 IP). We
also examined whether Gemin4 can be coimmunoprecipi-
tated with Gemin3, which is a recently identified novel
component of the SMN complex (Charroux et al., 1999).
Fig. 4 A shows that, like SMN and Gemin2, Gemin4 is
present in the anti-Gemin3 (lane 11G9 IP) immunoprecip-
itate (Charroux et al., 1999). In a reciprocal experiment,
the Gemin4 protein could also be coimmunoprecipitated
by the anti-SMN, the anti-Gemin2, and the anti-Gemin3
mAbs (Fig. 4 B). No SMN, Gemin2, Gemin3, or Gemin4
proteins were detected in the control nonimmune (SP2/0)
immunoprecipitate (data not shown and lane SP2/O, Fig. 4
B). These results suggest that SMN, Gemin2, Gemin3, and
Gemin4 are associated in vivo in one or more complexes
that can be immunoprecipitated by either anti-SMN, anti-
Gemin2, anti-Gemin3, or anti-Gemin4 antibodies.
Further support for the existence in vivo of a single com-
plex that contains SMN, Gemin2, Gemin3, and Gemin4
was obtained from gel filtration experiments. Total HeLa
extract was fractionated on a Superose 6 HR 10/30 high
performance gel filtration column; fractions were resolved
by SDS-PAGE, blotted, and probed with anti-SMN, anti-
Gemin2, anti-Gemin3, and anti-Gemin4 antibodies. SMN,
Gemin2, Gemin3, and Gemin4 comigrated and showed a
peak at 
 
z
 
800 kD, indicating that they are components of a
large macromolecular complex (Fig. 4 B). Gemin4 is also
detected in a second complex of 
 
z
 
550 kD that lacks SMN
and Gemin2 but does contain a faster migrating form of
Gemin3. Thus, there appear to be at least two different
Gemin4-containing complexes.
Figure 2. mAb 22C10 is specific for Gemin4. (A) Myc-tagged
Gemin4, hnRNP A1, and SMN proteins were produced in rabbit
reticulocyte lysate in the presence of [35S]methionine. The la-
beled proteins were immunoprecipitated using mAb 22C10, and
the immunoprecipitated material was analyzed by SDS-PAGE
and autoradiography. The left panel shows 10% of the in vitro
translated proteins. (B) Immunoblotting using mAb 22C10 on to-
tal HeLa extract. (C) Immunoprecipitations using anti-Gemin4
mAb 22C10 and [35S]methionine-labeled HeLa or mouse 3T3 cell
extracts. The immunoprecipitated proteins were analyzed by
SDS-PAGE and autoradiography. The position of the molecular
mass markers is indicated on the left in kilodaltons. 
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A second peak containing SMN and Gemin2, but lack-
ing Gemin3 and Gemin4, is observed at lower molecular
mass fractions that correspond to 
 
z
 
100 kD. The SMN pro-
tein present in these fractions was not detectable with a
rabbit polyclonal antibody specific to the peptide se-
quence encoded by exon 7 of SMN (Liu et al., 1997; Fig. 4
B). Thus, this smaller SMN–Gemin2 complex contains the
oligomerization-deficient form of SMN lacking amino ac-
ids encoded by exon 7, which is most likely produced by
the SMN2 gene (see Discussion; Gennarelli et al., 1995;
Lefebvre et al., 1995; Pellizzoni et al., 1999).
 
Gemin4 Interacts Tightly with the DEAD Box
Protein Gemin3
 
To investigate the interactions of Gemin4, we performed
in vitro protein binding assays using Gemin4 and several
constituents of the SMN complex. For this assay, purified
 
GST or GST-Gemin4 fusion immobilized on gluthathione-
Sepharose were incubated with [
 
35
 
S]methionine-labeled
SMN, Gemin2, Gemin3, and Gemin4 produced by in vitro
transcription and translation in rabbit reticulocyte lysate.
As shown in Fig. 5 A, full-length Gemin3 is the only pro-
tein of the SMN complex that binds specifically to immo-
bilized GST-Gemin4 (Fig. 5 A). No binding to GST alone
was observed (data not shown).
To further investigate this interaction, Gemin3 was ex-
pressed as a fusion protein with GST, and Gemin4 was
produced and labeled with [
 
35
 
S]methionine in rabbit
reticulocyte lysate. GST-Gemin3 fusion was incubated
with labeled Gemin4 in the presence of increasing salt
concentrations. As shown in Fig. 5 B, full-length Gemin4
bound to GST-Gemin3, and this binding appears to be
avid because it is not disrupted at 750 mM NaCl. No bind-
ing of Gemin4 to GST alone was detected (data not
shown).
Figure 3. The Gemin4 protein colocalizes with
SMN in gems and is detected in nucleoli. (A) La-
ser confocal image of indirect immunofluores-
cence on HeLa cells using mAb 22C10 against the
Gemin4 protein, arrows in A indicate gems. (B
and C) Superimposed laser confocal images of
double label immunofluorescence microscopy
experiments using antibodies against p80 coilin
(B and C, red), SMN (B, green), and Gemin4 (C,
green). (D) Differential interference contrast im-
age of the same cell shown in C, arrows indicate
gems and arrowheads indicate CBs. (E) Super-
imposed laser confocal images of double label
immunofluorescence microscopy experiments
using mAb against Gemin4 (green) and a rabbit
affinity-purified antibody against exon 7 epitope
of the human SMN protein (red). (F) Superim-
posed laser confocal images of double label im-
munofluorescence microscopy experiments us-
ing mAbs against Gemin4 (green) and against
fibrillarin (red). Dashed lines demarcate the nu-
cleus. A is a z-series composite stack of confocal
sections that shows the cytoplasmic staining of
Gemin4. B, C, E, and F, are confocal sections
through the nucleus that underestimate the cyto-
plasmic staining of Gemin4 and/or SMN. 
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Gemin4 Is Associated with Spliceosomal snRNPs in
the Cytoplasm
 
To further characterize the Gemin4 complex, immunopre-
cipitations using anti-Gemin4 mAbs from [
 
35
 
S]methionine-
labeled HeLa cells were carried out, and the immuno-
precipitated proteins were analyzed by SDS-PAGE. As
references for these immunoprecipitations, we also per-
formed immunoprecipitation with the anti-Sm mAb Y12
(Lerner and Steitz, 1979; Lerner et al., 1981) and with the
anti-SMN mAb 2B1. As shown in Fig. 6 A, several pro-
teins are coimmunoprecipitated with anti-Gemin4 anti-
bodies, and the pattern is very similar to the one obtained
with anti-SMN antibodies. Besides SMN, Gemin2, Gem-
in3, and Gemin4, the Sm core proteins B/B
 
9
 
, D1-3, E, F,
and G proteins were also coimmunoprecipitated with the
22C10 anti-Gemin4 antibody. Additional proteins coim-
munoprecipitated specifically with anti-SMN (at 175, 95,
60, and 50 kD) or anti-Gemin4 (at 80 kD) mAbs. Note
that the U1-specific A protein, but not the U1-specific C
protein, coimmunoprecipitates with SMN and Gemin4.
This indicates that the SMN complexes are not associated
with mature snRNP particles.
The in vivo association of Gemin4 with the Sm proteins
was confirmed by a coimmunoprecipitation and Western
blot experiment. The anti-Sm mAb Y12 was used for im-
munoprecipitation from HeLa cell total extracts, and the
immunoprecipitate was analyzed by SDS-PAGE and an
immunoblot with the anti-Gemin4 antibody 22C10. As
shown in Fig. 6 B, 22C10 readily detects Gemin4 in the
Y12 immunoprecipitate, demonstrating that Gemin4 is as-
sociated with the Sm proteins in vivo. To investigate
whether Gemin4 interacts with Sm proteins directly, puri-
fied recombinant GST-Gemin4 protein was used for bind-
ing assays with in vitro produced [
 
35
 
S]methionine-labeled
Sm proteins. Fig. 6 C shows that the Sm proteins B, D1,
D2, D3, and E bind to GST-Gemin4, whereas there is no
detectable binding to GST alone (data not shown). To de-
termine if Gemin4 is able to interact directly with the Sm
proteins and not via other components of the SMN com-
plex that may be present in the rabbit reticulocyte lysate,
recombinant His-tagged SmB protein was produced and
Figure 4. Gemin4 is in a complex with SMN, Gemin2, and
Gemin3. (A and B) SMN, Gemin2, Gemin3, and Gemin4 can be
coimmunoprecipitated in vivo. (A) mAbs against Gemin4 coim-
munoprecipitate SMN, Gemin2, and Gemin3. Immunoprecipita-
tion from total the HeLa extract was done with mAb anti-Gemin4
(22C10) and the immunoprecipitated proteins were analyzed by
Western blot using 2B1 (anti-SMN), 2S7 (anti-Gemin2), or 11G9
(anti-Gemin3) antibodies. (B) mAbs against SMN, Gemin2, and
Gemin3 coimmunoprecipitate Gemin4. Immunoprecipitation
from total HeLa extract was done with mAb anti-SMN (lane 2B1
IP), anti-Gemin2 (lane 2S7 IP), anti-Gemin3 (lane 11G9 IP), or
SP2/O (lane SP2/O IP) as a negative control. The immunoprecip-
itated proteins were analyzed by Western blot using the anti-
Gemin4 mAb 22C10. The position of the molecular mass mark-
ers is indicated on the left (in kD) and the positions of the light
chain (l.c) and heavy chain (h.c) of the antibodies used for immu-
noprecipitation are indicated. (C) Gel filtration analysis of SMN
complexes. Total HeLa extract was fractionated on a Superose 6 HR
10/30 column. The fractions were analyzed by SDS-PAGE, and
SMN, Gemin2, Gemin3, and Gemin4 proteins were detected by
Western blotting. The fraction number and the molecular mass
standards are indicated.
Figure 5. Gemin4 interacts
directly with the DEAD box
protein Gemin3 in vitro. (A)
Gemin4 interacts with
Gemin3 in vitro. In vitro
translated [35S]methionine-
labeled myc-tagged SMN,
Gemin2, Gemin3, and
Gemin4 proteins were incu-
bated with purified GST-
Gemin4 as described in Ma-
terials and Methods. Bound
proteins were analyzed by
SDS-PAGE and fluorogra-
phy. The in vitro translation
panel shows 5% of the input.
The position of the molecu-
lar mass markers is indicated
on the left in kilodaltons. (B)
Gemin4 interacts tightly with
Gemin3. In vitro translated
[35S]methionine-labeled myc-
Gemin4 was incubated with
purified GST-Gemin3 in in-
creasing salt concentrations
as indicated (see Materials and Methods). Bound proteins were
analyzed by SDS-PAGE and fluorography. The in vitro transla-
tion panel shows 10% of the input. 
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incubated with GST or GST-Gemin4. Bound proteins
were resolved by SDS-PAGE, and analyzed by Western
blotting with a rabbit polyclonal antibody specific to the
6xHis-tag. As shown in Fig. 6 D, SmB binds specifically to
Gemin4 but not to GST. We conclude that Gemin4 inter-
acts directly with SmB.
To determine whether Gemin4 was associated with sn-
RNAs in vivo, we used the 
 
Xenopus
 
 oocyte that provides a
particularly advantageous system in which to study spli-
ceosomal snRNP biogenesis by use of microinjection
(Mattaj and De Robertis, 1985; Mattaj, 1986). We first
wished to determine whether Gemin4 is present in 
 
Xeno-
pus
 
 cells and whether it can be recognized by 22C10 anti-
body. The 22C10 mAb showed both gems and nucleolar
staining on 
 
Xenopus
 
 XL177 somatic cells, strongly sug-
gesting that Gemin4 is conserved in 
 
Xenopus
 
 (data not
shown). However, immunoblotting with the anti-human
Gemin4 mAb 22C10 on 
 
Xenopus
 
 tissue culture cells or on
 
Xenopus
 
 oocyte lysates did not detect any protein (data
not shown). To determine if Gemin4 is associated with
U snRNAs in vivo, various 
 
32
 
P-labeled RNAs includ-
ing chicken 
 
d
 
-crystallin mRNA, chicken 
 
d
 
-crystallin pre-
mRNA, and the spliceosomal snRNAs U1 and U5 were
produced by in vitro transcription and a mixture of these
RNAs was microinjected into the cytoplasm of oocytes.
After 3 h, immunoprecipitations were carried out with
anti-Gemin4 (22C10) and, as a positive control, anti-
Gemin2 (2E17) antibodies (Fischer et al., 1997). Fig. 7 A
shows that only U1 and U5 snRNAs are efficiently and
specifically precipitated, indicating that they associate with
Gemin4. A similar, but less efficient, immunoprecipitation
of U1 and U5 snRNAs was observed with the anti-Gemin2
antibody. We further asked whether the other spliceoso-
mal U snRNAs, U2 and U4, were associated with Gemin4
as well, and whether the association of Gemin4 with ma-
ture U snRNPs was also observed in the nucleus. To do so,
a mixture of 
 
32
 
P-labeled U snRNAs were injected into the
cytoplasm of oocytes followed by an 18-h incubation (Fig.
7 B). After this incubation period, 
 
z
 
50% of the injected
snRNA was imported into the nucleus while the rest re-
mained in the cytoplasm. Immunoprecipitations from the
nuclear and cytoplasmic fractions were carried out with ei-
ther anti-Gemin4 antibody, anti-Sm antibody as a positive
control, or SP2/O as a negative control. The coimmuno-
precipitated RNAs were analyzed by gel electrophore-
sis. As previously reported, U1, U2, U4, and U5 were ef-
ficiently immunoprecipitated by Y12 in approximately
equal amounts from the nucleus and the cytoplasm (Fig. 7
B; Mattaj, 1986; Fisher and Luhrmann, 1990). In contrast,
Gemin4 associated more efficiently with U1 and U5 than
U2 and U4, and this association was only observed in the
cytoplasm (Fig. 7 B).
We conclude that the Gemin4, like SMN and Gemin2, is
stably associated with U1 and U5 snRNAs in the cyto-
plasm of 
 
Xenopus
 
 oocytes but not after these snRNAs
have been assembled into snRNPs and imported into the
nucleus. Thus, like SMN and Gemin2 (Fisher et al., 1997),
Gemin4 likely dissociates from the spliceosomal snRNPs
either immediately before nuclear entry or shortly there-
after.
Figure 6. Gemin4 is associated with snRNPs in vivo.
(A) Immunoprecipitations of [35S]methionine-labeled
total HeLa cell extract using mAbs specific to SMN
(2B1), Gemin4 (22C10), and the snRNP Sm core
proteins (Y12). The immunoprecipitated proteins
were analyzed by SDS-PAGE and autoradiography.
The several proteins immunoprecipitated are indi-
cated on the right. (B) Gemin4 is coimmunoprecipi-
tated with Sm proteins. Immunoprecipitation from
the total HeLa extract was performed with mAb
anti-Sm (Y12) and the immunoprecipitated proteins
were analyzed by Western blotting using 22C10
(anti-Gemin4). The position of the molecular mass
markers is indicated on the left (in kD). The posi-
tions of the light chain (l.c) and heavy chain (h.c) of
the antibody used for immunoprecipitation are indi-
cated. The total lane shows 2% of the input. (C)
Gemin4 interacts with several Sm proteins in vitro.
In vitro translated [35S]methionine-labeled myc-
tagged Sm proteins B, D1, D2, D3, E, F, and G were
incubated with purified GST-Gemin4 as described
in Materials and Methods. Bound proteins were an-
alyzed by SDS-PAGE and fluorography. The in
vitro translation panel shows 5% of the input. The
position of the molecular mass markers is indicated
on the left in kilodaltons. (D) Gemin4 interacts di-
rectly with SmB in vitro. Recombinant His-tagged
SmB protein was incubated with purified GST or
GST-Gemin4 proteins as described in Materials and
Methods. Bound proteins were analyzed by SDS-
PAGE and Western blotting with an anti-His tag
antibodies. 
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Discussion
 
Using a biochemical approach to characterize additional
components of the SMN complex, we have identified a
novel protein termed Gemin4. Gemin4 does not contain
any known or recognizable protein motifs. Several lines
of evidence suggest that Gemin4, together with SMN,
Gemin2, and Gemin3, function as a complex in vivo. SMN,
Gemin2, Gemin3, and Gemin4 can be coimmunoprecipi-
tated, and are present in a large complex that also contains
the spliceosomal snRNP core Sm proteins. Like SMN and
Gemin3, Gemin4 interacts directly with several snRNP Sm
core proteins, including B/B
 
9
 
, D1-D3, and E and is associ-
 
ated with U1 and U5 snRNAs in the cytoplasm of 
 
Xeno-
pus
 
 oocytes, where snRNP assembly takes place (Liu et al.,
1997; Fischer et al., 1997; Charroux et al., 1999; Pellizzoni
et al., 1999). We have previously shown that the SMN
complex plays a critical role in spliceosomal snRNP as-
sembly in the cytoplasm, and is required for pre-mRNA
splicing in the nucleus (Fischer et al., 1997; Pellizzoni et al.,
1998). Thus, it is likely that Gemin4 also plays an impor-
tant role in these processes. Note, that so far, we have not
been able to detect any effect of anti-Gemin4 antibody
22C10 on snRNP assembly and/or snRNP import into the
nucleus upon microinjection into 
 
Xenopus
 
 oocytes (data
not shown).
Unlike Gemin2 and Gemin3, Gemin4 does not interact
with SMN directly and its presence in the SMN complex is
probably the result of its direct and stable interaction with
Gemin3. The observation that Gemin4 and the DEAD
box protein Gemin3 interact with each other directly and
avidly suggests that they function together. Previous stud-
ies have shown that the RNA helicase activity of the trans-
lation initiation factor eIF4A, also a DEAD box protein, is
dependent on the presence of a second initiation factor,
eIF4B. Interestingly, in a series of preliminary experi-
ments we have so far not been able to detect RNA heli-
case or RNA-dependent ATPase activity for recombinant
Gemin3 (Charroux et al., 1999). It is possible that such ac-
tivity will only manifest itself when Gemin3 is associated
with other proteins such as Gemin4.
Gel filtration experiments revealed the presence of two
SMN complexes in HeLa cells. The high molecular mass
complex is the most abundant and contains all the compo-
nents of the SMN complex thus far identified (SMN,
Gemin2, Gemin3, and Gemin4) and likely represents an
active form of the complex (see below). The large size of
this complex is likely the result of the capacity of SMN to
form large oligomers (Pellizzoni et al., 1999). The second
complex probably represents a monomeric, COOH-termi-
nal–truncated form of SMN (SMN
 
D
 
Ex7) associated with
Gemin2 (Pellizzoni et al., 1999). While 
 
SMN1
 
 produces
only full-length mRNA, 
 
SMN2
 
 mainly produces an alter-
natively spliced form of SMN mRNA lacking exon 7
(Gennarelli et al., 1995; Lefebvre et al., 1995). Exon 7
skipping is due to the presence of a single nucleotide
change in the 
 
SMN2
 
 gene compared with 
 
SMN1
 
 (Lorson
et al., 1999), and the ratio of alternatively spliced versus
full-length 
 
SMN2
 
 mRNA correlates with the severity of
SMA (Gavrilov et al., 1998). Nevertheless, no evidence for
the presence of SMN protein lacking exon 7–encoded
amino acids in vivo has been reported. The absence of the
amino acid sequence encoded by exon7 is thought to gen-
erate a nonfunctional SMN protein that lacks the capacity
to oligomerize and, thus, cannot interact with Sm proteins
(Burghes, 1997; Lorson et al., 1998; Pellizzoni et al., 1999).
The absence of Gemin3 and Gemin4 from the SMN
 
D
 
Ex7–
Gemin2 complex probably results from the defective in-
teraction of SMN
 
D
 
Ex7 with Gemin3 (Charroux et al.,
1999). We have shown that SMN
 
D
 
Ex7 is a nonfunctional
protein that is incapable, unlike wild-type SMN, of regen-
erating splicing extracts in vitro (Pellizzoni et al., 1998).
Thus, the loss of function of SMN
 
D
 
Ex7 is likely due to
its defective interaction with the Sm proteins as well as
with the Gemin3–Gemin4 complex (Charroux et al., 1999;
Figure 7. Gemin4 is associated with spliceosomal U snRNAs in
the cytoplasm of Xenopus oocytes. (A) Immunoprecipitation of
spliceosomal U snRNAs with anti-Gemin2 and anti-Gemin4 an-
tibodies. A mixture of different in vitro synthesized 32P-labeled
RNAs were injected into the cytoplasm of oocytes. 3 h later, im-
munoprecipitations were carried out with either anti-Gemin4
(22C10) or anti-Gemin2 (2E17) or control antibodies (SP2/O).
Immunoprecipitated RNA (IP) was analyzed by gel electro-
phoresis. In the supernatant (SUP) panel 2.5% of each immuno-
precipitation is shown. (B) Anti-Gemin4 antibodies can immuno-
precipitate U1 and U5 snRNAs only from the cytoplasm. The
indicated 32P-labeled RNAs were injected as a mixture into the
cytoplasm of oocytes. After incubation for 18 h, the oocytes were
dissected into nuclear (N) and cytoplasmic (C) fractions, and
RNAs from both fractions were immunoprecipitated (IP) with
either anti-Gemin4 (22C10), anti-Sm (Y12), or control antibodies
(SP2/O). 2.5% of the input is shown. 
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Pellizzoni et al., 1999). Therefore, we suggest that the
SMN
 
D
 
Ex7–Gemin2 complex represents an inactive form of
the SMN complex, whereas the high molecular mass com-
plex containing SMN, Gemin2, Gemin3, and Gemin4 repre-
sents the active complex that can bind substrates such as the
Sm proteins and carry out the functions of the complex (Fig.
8; Fischer et al., 1997, Pellizzoni et al., 1998, 1999).
Higher eukaryotic nuclei contain numerous morpholog-
ically distinct substructures or nuclear bodies (for reviews
see Singer and Green, 1997; Lamond and Earnshaw, 1998;
Matera, 1999). SMN, Gemin2, Gemin3, and Gemin4, in
addition to their general localization in the cytoplasm, are
found in the nucleus, where they are concentrated in gems
(Liu and Dreyfuss, 1996; Liu et al., 1997). Gems are similar
in size and number to CBs, and these two bodies are often
found either entirely merged or in close proximity (Liu
and Dreyfuss, 1996; Liu et al., 1997; Matera and Frey,
1998). CBs are highly enriched in snRNPs and snoRNPs
and, together with gems, appear to be involved in snRNP
biogenesis and metabolism (Gall et al., 1995; Lamond and
Earnshaw, 1998; Pellizzoni et al., 1998; Matera, 1999; Slee-
man and Lamond, 1999). In addition to its localization in
gems, Gemin4 is in the nucleoli and, thus, represents the
first component of the SMN complex present in this nu-
clear compartment. Using a different polyclonal anti-SMN
antibody from 2B1, others have observed a strong nucle-
olar immunolocalization of SMN in mouse and human
CNS tissues (Francis et al., 1998). However, SMN has not
been detected in nucleoli of HeLa cells. Interestingly, SMN
interacts with fibrillarin (Liu and Dreyfuss, 1996), a com-
mon component of small nucleolar RNPs (snoRNPs).
 
Fibrillarin is found in the nucleoli and in CBs and may be
the snoRNP’s functional equivalent of the core Sm pro-
teins of spliceosomal snRNPs (Tyc and Steitz, 1989; Max-
well and Fournier, 1995; Smith and Steitz, 1997). Because
of their close association with nucleoli, it has been sug-
gested that CBs participate in snoRNP biogenesis and/or
metabolism (Raska et al., 1990). Given the close associa-
tion between CBs and gems and the interaction between
SMN and fibrillarin, it is possible that the SMN complex
also plays a role in snoRNP assembly and ribosomal RNA
metabolism. Therefore, Gemin4 may function to connect
SMN to both UsnRNA biogenesis and rRNA biogenesis.
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